Cytosorbents PE Ratio 2010-2025 | CTSO
Current and historical p/e ratio for Cytosorbents (CTSO) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cytosorbents PE ratio as of July 11, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Cytosorbents PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-11 | 1.06 | 0.00 | |
| 2025-03-31 | 1.00 | $-0.28 | 0.00 |
| 2024-12-31 | 0.91 | $-0.38 | 0.00 |
| 2024-09-30 | 1.50 | $-0.36 | 0.00 |
| 2024-06-30 | 0.70 | $-0.53 | 0.00 |
| 2024-03-31 | 0.95 | $-0.59 | 0.00 |
| 2023-12-31 | 1.11 | $-0.64 | 0.00 |
| 2023-09-30 | 1.88 | $-0.53 | 0.00 |
| 2023-06-30 | 3.59 | $-0.60 | 0.00 |
| 2023-03-31 | 3.37 | $-0.71 | 0.00 |
| 2022-12-31 | 1.55 | $-0.75 | 0.00 |
| 2022-09-30 | 1.36 | $-0.95 | 0.00 |
| 2022-06-30 | 2.19 | $-0.82 | 0.00 |
| 2022-03-31 | 3.19 | $-0.68 | 0.00 |
| 2021-12-31 | 4.19 | $-0.57 | 0.00 |
| 2021-09-30 | 8.12 | $-0.36 | 0.00 |
| 2021-06-30 | 7.55 | $-0.23 | 0.00 |
| 2021-03-31 | 8.68 | $-0.20 | 0.00 |
| 2020-12-31 | 7.97 | $-0.20 | 0.00 |
| 2020-09-30 | 7.98 | $-0.33 | 0.00 |
| 2020-06-30 | 9.90 | $-0.52 | 0.00 |
| 2020-03-31 | 7.73 | $-0.55 | 0.00 |
| 2019-12-31 | 3.85 | $-0.60 | 0.00 |
| 2019-09-30 | 5.03 | $-0.64 | 0.00 |
| 2019-06-30 | 6.61 | $-0.53 | 0.00 |
| 2019-03-31 | 7.57 | $-0.61 | 0.00 |
| 2018-12-31 | 8.08 | $-0.56 | 0.00 |
| 2018-09-30 | 12.90 | $-0.51 | 0.00 |
| 2018-06-30 | 11.40 | $-0.48 | 0.00 |
| 2018-03-31 | 7.05 | $-0.33 | 0.00 |
| 2017-12-31 | 6.50 | $-0.28 | 0.00 |
| 2017-09-30 | 6.20 | $-0.32 | 0.00 |
| 2017-06-30 | 4.30 | $-0.36 | 0.00 |
| 2017-03-31 | 4.50 | $-0.44 | 0.00 |
| 2016-12-31 | 5.45 | $-0.47 | 0.00 |
| 2016-09-30 | 6.40 | $-0.39 | 0.00 |
| 2016-06-30 | 4.55 | $-0.39 | 0.00 |
| 2016-03-31 | 3.92 | $-0.22 | 0.00 |
| 2015-12-31 | 5.57 | $-0.33 | 0.00 |
| 2015-09-30 | 6.31 | $-1.09 | 0.00 |
| 2015-06-30 | 6.14 | $-1.23 | 0.00 |
| 2015-03-31 | 13.19 | $-1.53 | 0.00 |
| 2014-12-31 | 9.95 | $-1.59 | 0.00 |
| 2014-09-30 | 5.75 | $-1.00 | 0.00 |
| 2014-06-30 | 6.05 | $-1.00 | 0.00 |
| 2014-03-31 | 5.75 | $-1.00 | 0.00 |
| 2013-12-31 | 3.13 | $-1.00 | 0.00 |
| 2013-09-30 | 2.50 | $-1.00 | 0.00 |
| 2013-06-30 | 3.00 | $-1.00 | 0.00 |
| 2013-03-31 | 2.94 | $-0.75 | 0.00 |
| 2012-12-31 | 3.25 | $-0.50 | 0.00 |
| 2012-09-30 | 3.29 | $-0.25 | 0.00 |
| 2012-06-30 | 3.20 | 0 | 0.00 |
| 2012-03-31 | 3.58 | 0 | 0.00 |
| 2011-12-31 | 4.00 | 0 | 0.00 |
| 2011-09-30 | 4.18 | 0 | 0.00 |
| 2011-06-30 | 5.08 | 0 | 0.00 |
| 2011-03-31 | 9.73 | 0 | 0.00 |
| 2010-12-31 | 3.50 | 0 | 0.00 |
| 2010-09-30 | 2.31 | 0 | 0.00 |
| 2010-06-30 | 2.18 | 0 | 0.00 |
| 2010-03-31 | 4.35 | 0 | 0.00 |
| 2009-12-31 | 4.75 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.066B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.693B | 27.62 |
| Boston Scientific (BSX) | United States | $152.679B | 38.22 |
| Stryker (SYK) | United States | $148.653B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $131.422B | 0.00 |
| Medtronic (MDT) | Ireland | $115.326B | 16.35 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.666B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.744B | 25.54 |
| ResMed (RMD) | United States | $37.302B | 28.02 |
| Agilent Technologies (A) | United States | $35.020B | 22.83 |
| GE HealthCare Technologies (GEHC) | United States | $34.401B | 16.33 |
| Terumo (TRUMY) | Japan | $24.607B | 31.96 |
| Koninklijke Philips (PHG) | Netherlands | $23.139B | 16.24 |
| Insulet (PODD) | United States | $20.361B | 79.92 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.556B | 11.92 |
| Baxter (BAX) | United States | $14.728B | 11.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.993B | 24.33 |
| Lantheus Holdings (LNTH) | United States | $5.626B | 14.19 |
| Perrigo (PRGO) | Ireland | $3.785B | 9.59 |
| Prestige Consumer Healthcare (PBH) | United States | $3.780B | 16.89 |
| Haemonetics (HAE) | United States | $3.628B | 16.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.424B | 28.45 |
| ICU Medical (ICUI) | United States | $3.253B | 23.99 |
| QuidelOrtho (QDEL) | United States | $2.052B | 14.11 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 42.26 |
| AtriCure (ATRC) | United States | $1.521B | 0.00 |
| Acuren (TIC) | United States | $1.395B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.389B | 31.24 |
| Phibro Animal Health (PAHC) | United States | $1.248B | 15.96 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Neogen (NEOG) | United States | $1.170B | 14.97 |
| BioLife Solutions (BLFS) | United States | $1.050B | 0.00 |
| InMode (INMD) | Israel | $0.930B | 9.37 |
| Curaleaf Holdings (CURLF) | Canada | $0.771B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.766B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.695B | 0.00 |
| Owens & Minor (OMI) | United States | $0.627B | 5.21 |
| Evolus (EOLS) | United States | $0.611B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.584B | 0.00 |
| CeriBell (CBLL) | United States | $0.583B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.349B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.38 |
| Cresco Labs (CRLBF) | United States | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Quanterix (QTRX) | United States | $0.294B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.83 |
| ZimVie (ZIMV) | United States | $0.251B | 11.39 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Brainsway (BWAY) | Israel | $0.233B | 61.55 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Biote (BTMD) | United States | $0.223B | 6.28 |
| Omeros (OMER) | United States | $0.214B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.68 |
| Jushi Holdings (JUSHF) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.081B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Agape ATP (ATPC) | $0.074B | 0.00 | |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.068B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.43 |
| United-Guardian (UG) | United States | $0.037B | 12.89 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |